Inventiva (IVA) Shares Outstanding (2019 - 2025)
Inventiva (IVA) posted quarterly Shares Outstanding (Entity) of $69186.0 for Q4 2025, up 15.74% year-over-year from $59779.0 in Q4 2024, and up 71.63% quarter-over-quarter from $40311.0 in Q2 2025.
Inventiva (IVA) Shares Outstanding (2019 - 2025) Analysis & Trends
Inventiva's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $69186.0 for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 15.74% year-over-year to $69186.0; the TTM figure through Dec 2025 stood at $69186.0 (up 15.74% YoY), while the FY2025 annual figure was $69186.0, up 15.74% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $69186.0, up from $40311.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $41.4 million in Q4 2022, with the low at $41.0 in Q2 2022.
- The 5-year median for Shares Outstanding (Entity) is $55880.5 (2024), against an average of $12.0 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) tumbled 100.0% in 2022, then jumped 102448.78% in 2023.
- Inventiva's Shares Outstanding (Entity) stood at $39.2 million in 2021, then gained by 5.83% to $41.4 million in 2022, then slumped by 99.91% to $37793.0 in 2023, then surged by 58.17% to $59779.0 in 2024, then gained by 15.74% to $69186.0 in 2025.
- Business Quant data shows IVA's Shares Outstanding (Entity) at $69186.0 in Q4 2025, $40311.0 in Q2 2025, and $59779.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | 186.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 186.80 Mn |
| Jun 30, 2025 | 108.84 Mn |
| Dec 31, 2024 | 59.78 Mn |
| Jun 30, 2024 | 51.98 Mn |
| Dec 31, 2023 | 45.35 Mn |
| Oct 11, 2023 | 42.04 Mn |
| Jun 30, 2023 | 42.04 Mn |
| Dec 31, 2022 | 41.45 Mn |
| Sep 22, 2022 | 40.86 Mn |
| Jun 30, 2022 | 40.86 Mn |
| Dec 31, 2021 | 39.17 Mn |
| Jun 30, 2021 | 38.68 Mn |
| Mar 31, 2021 | 33.87 Mn |
| Dec 31, 2020 | 33.87 Mn |
| Jun 30, 2020 | 29.89 Mn |
| Mar 31, 2020 | 23.52 Mn |
| Dec 31, 2019 | 23.52 Mn |